Elisabetta Setola, MD

Photo Elisabetta Setola, MD
Elisabetta Setola, Dr.ssa

Personal information - Education and work experience

MD, Oncologist


  • 1999: Degree in Medicine and Surgery, University of Bologna, with honors.
  • 1999: Diploma at Classical Lyceum GB Morgagni, Forlì.

2003: Specialization in Oncology at the University of Bologna.

  • 2017: Osteoncology and Rare Tumors Center, IRST (Scientific Institute of Romagna for the Study and Cure of Tumors) Meldola (FC, Italy).
  • 2009-2017: Consultant in Medical Oncology at the San Giuseppe Multimedica Hospital, Milan: genaral oncology and rare tumors.
  • 2004-2009: Consultant in medical Oncoloy at the Istituto San Raffaele G.Giglio Foundation, Cefalù: start-up of a new oncology service. Clinical Day Hospital activity, inpatient and outpatient services. Cinical research. Partnership with the San Raffaele Hospital in Milan.
  • 2003- 2004: MD, Oncologist at the Rizzoli Orthopaedic Institute, Oncology Unit.

Italian: mother tongue.

English: IELTS band 7 (C1).

Microsoft Office.

Good abilities in teaching.

Clinical research:

  • 2003: Clinical research at Rizzoli Orthopaedic Institute, Bologna.
  • 2002-2003: Haematology and Bone Marrow Transplantation at the San Raffaele Hospital, Milan: autologous and allogenic transplant for solid tumors, gene therapy, cellular therapy.
  • 2000: International Visiting Scholars Program, at the H. Lee Moffitt Cancer Center & Research Institute, Tampa Florida: Senior Adult Oncology Program, Hematology, Comprehensive Breast Program, Sarcoma Program, Genitourinary Oncology Program, Radiation Oncology Program, Head & Neck Oncology Program, Pathology Genetics and Neuro Oncology.


  • 2009: Palliative care course.
  • 2003-2009: Attending at EBMT Solid Tumors Working Party.
  • 2003: Course on musculoscheletal pathology, Rizzoli Orthopaedic Institute.
  • 2003, 2004, 2008: Course on bone marrow transplantation in solid tumours.

Affiliation: ISG, AIOM, ESMO.
Pubblications in national and international journals (> 15).

Bone Tumors, soft tissue sarcomas, rare tumors, immunotherapy in solid tumors.

Content updated 16/11/2017 - 16:28
Utilizza SharethisShareThis  Scrivi una email  Vai a facebook  Vai a twitter